About Dr. Ravi B. Diwakar
Dr. Ravi B. Diwakar is a senior medical oncologist experienced in treating a broad spectrum of cancers in both adults and children. His clinical focus includes breast, colon, stomach, mouth, lung cancers, and hematologic malignancies such as leukemia and lymphoma. He is highly skilled in high-dose chemotherapy, immunotherapy, targeted therapy, and bone marrow transplantation. Known for his research contributions and patient-centered care, Dr. Diwakar combines evidence-based treatments with empathy and clear communication, ensuring personalized oncology care for every patient. His approach consistently delivers improved outcomes and high patient satisfaction across complex cancer cases.
- MBBS: Gulbarga University (M R Medical College, Gulbarga)
- MD (General Medicine): Mangalore University, Karnataka (Kasturba Medical College, Mangalore)
- DM (Medical Oncology): The Tamil Nadu Dr. M.G.R. Medical University (TNMGRMU), Chennai (Cancer Institute of Adyar, Madras)
- Breast Cancer
- Colon Cancer
- Stomach Cancer
- Mouth Cancer
- Lung Cancer
- Haematological Neoplasms (Leukaemia, Lymphoma, Myeloma)
- Adult Solid Tumours
- Paediatric Solid Tumours
- Medical Oncology
- Haemato-Oncology
- Bone Marrow Transplantation (Autologous and Allogeneic)
- Peripheral Stem Cell Transplantation
- Immunotherapy
- High-Dose Chemotherapy
- High-Dose Chemotherapy
- Autologous Bone Marrow Transplantation
- Allogeneic Bone Marrow Transplantation
- Peripheral Stem Cell Collection and Transplantation
- Immunotherapy
- Targeted Therapy
- Malignant Mastectomy
- Fibroadenoma Breast Removal
- Lumpectomy or Sector Mastectomy
- Mastectomy-Lumpectomy or Sector with Axillary Clearance
- Splenectom
- HIPEC/PIPAC
- Consultant Medical Oncologist: HCG Cancer Centre – Bangalore (Present)
- Consultant Medical Oncologist: Sagar Hospital, Kumaraswamy Layout, Bangalore
- Consultant, Medical Oncology: Bangalore Institute of Oncology, Bangalore
- Consultant, Medical Oncology: CSI Hospital, Bangalore
- Consultant, Medical Oncology: Mallya Hospital, Bangalore
- Member, Indian Medical Association (IMA)
- Member, Bangalore Oncology Group (BOG)
- Member, Indian Society of Oncology (ISO)
- Member, Indian Society of Medical and Paediatric Oncology (ISMPO)
- Auditory function and quality of life in patients receiving cisplatin chemotherapy in head and neck cancer: A case series follow-up study. Journal of Cancer Research and Therapeutics (2018)
- Effect of Yoga on Sleep Quality and Neuroendocrine Immune Response in Metastatic Breast Cancer Patients. Indian Journal of Palliative Care (2017)
- Prevalence of KRAS mutations in metastatic colorectal cancer: A retrospective observational study from India. Indian Journal of Cancer (2014)
- Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study. Onco Targets Ther (2014)
- Epidermal growth factor receptor mutation in non-small-cell lung carcinomas: A retrospective analysis of 1036 lung cancer specimens from a network of tertiary cancer care centers in India. Indian Journal of Cancer (2013)
- Analysis of pretreatment nonpharmacologic, pharmacologic factors, and yoga intervention on CINV outcomes in breast cancer patients undergoing adjuvant chemotherapy. Journal of Clinical Oncology (2012)
- Pathologic complete response rates following neoadjuvant chemotherapy in the treatment of locally advanced breast cancer. Journal of Clinical Oncology (2011)
- Anxiolytic effects of a yoga program in early breast cancer patients undergoing conventional treatment: A randomized controlled trial. Complementary Therapies in Medicine (2009)
- Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers. Translational Oncology (2022)
- Contributed chapter on “Endocrine manipulation in Breast cancer” in Synopsis of Breast Cancer.
- Contributed chapter on “Management of Metastatic Breast Cancer” in Consensus on Breast Cancer.
Treatment/Procedure | Estimated Cost in INR (₹) | Estimated Cost in USD ($) |
Chemotherapy (per cycle) | 70,000 – 3,00,000+ | 850 – 3,600+ |
Immunotherapy (per cycle) | 1,50,000 – 4,00,000+ | 1,800 – 4,800+ |
Targeted Therapy (monthly) | 1,00,000 – 5,00,000+ | 1,200 – 6,000+ |
Autologous Bone Marrow Transplant | 12,00,000 – 20,00,000+ | 14,500 – 24,000+ |
Allogeneic Bone Marrow Transplant | 20,00,000 – 35,00,000+ | 24,000 – 42,000+ |